Edwards Lifesciences (EW) Current Deferred Tax Assets (2009 - 2015)

Edwards Lifesciences' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $79.0 million for Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 167.8% year-over-year to $79.0 million in Q3 2015; TTM through Sep 2015 was $79.0 million, a 167.8% increase from a year earlier, with the FY2014 full-year figure at $63.5 million, up 90.12% from the prior year.
• Current Deferred Tax Assets advanced to $79.0 million in Q3 2015 per EW's latest filing, from $65.2 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $79.0 million in Q3 2015 and bottomed at $25.3 million in Q3 2011.
• The 5-year median for Current Deferred Tax Assets is $42.4 million (2012), against an average of $44.9 million.
• Across the five-year window, Current Deferred Tax Assets sank 43.57% in 2012 and jumped 167.8% in 2015, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $43.9 million in 2011, then retreated by 1.14% to $43.4 million in 2012, then slipped by 23.04% to $33.4 million in 2013, then surged by 90.12% to $63.5 million in 2014, then advanced by 24.41% to $79.0 million in 2015.
• Per Business Quant, the three latest EW Current Deferred Tax Assets figures stand at $79.0 million (Q3 2015), $65.2 million (Q2 2015), and $57.0 million (Q1 2015).